| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |